EPC-K1 reduces the expression of inducible nitric oxide synthase (iNOS) in delayed neuronal death (DND).
Matsuo
Koushun
K
Department of Neurology, Saiseikai Shiga Hospital, Ohashi 2-4-1, Ritto, Shiga 520-3046, Japan. ssh@mx.biwa.ne.jp
Mori
Satoru
S
Ijichi
Toshiharu
T
Nakajima
Kenji
K
Kokufu
Takatoshi
T
Ihara
Norihiko
N
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016923:Cell Death; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D005849:Gerbillinae; D002546:Ischemic Attack, Transient / Q000201:enzymology* / Q000235:genetics; D009474:Neurons / Q000201:enzymology* / Q000473:pathology; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D019001:Nitric Oxide Synthase / Q000235:genetics*; D052247:Nitric Oxide Synthase Type II; D014810:Vitamin E / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D000975:Antioxidants; D018696:Neuroprotective Agents; D014810:Vitamin E; C066638:potassium ascorbyl tocopheryl phosphate; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; D001205:Ascorbic Acid